---
title: "Jade Biosciences, Inc. (JBIO.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/JBIO.US.md"
symbol: "JBIO.US"
name: "Jade Biosciences, Inc."
industry: "Biotechnology"
datetime: "2026-06-10T12:59:42.268Z"
locales:
  - [en](https://longbridge.com/en/quote/JBIO.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/JBIO.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/JBIO.US.md)
---

# Jade Biosciences, Inc. (JBIO.US)

## Company Overview

Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [jadebiosciences.com](https://jadebiosciences.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -7.90 | 425 | - | - | - |
| PB | 2.53 | 227 | 3.96 | 3.12 | 1.48 |
| Dividend Yield | 0.00% | - | 31.87% | 26.11% | 22.90% |

## Institutional View

### Analyst Rating Distribution

> As of 2026-06-01T04:00:00.000Z

Total Analysts: **9**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 9 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 10.48 |
| Highest Target | 19.00 |
| Lowest Target | 14.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/JBIO.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/JBIO.US/norm.md)
- [Related News](https://longbridge.com/en/quote/JBIO.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/JBIO.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**